Comparison of the efficacy of the tumour necrosis factor alpha blocking agents etanercept and infliximab in patients with active rheumatoid arthritis

被引:0
|
作者
De Filippis, LG [1 ]
Caliri, A [1 ]
Scibilia, G [1 ]
Miceli, G [1 ]
Romano, C [1 ]
Sangari, D [1 ]
Bartolone, S [1 ]
Lo Gullo, R [1 ]
Bagnato, G [1 ]
机构
[1] Univ G Martino, Policlin, Rheumatol Unit, Messina, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:411 / 411
页数:1
相关论文
共 50 条
  • [41] Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation
    Malottki, K.
    Barton, P.
    Tsourapas, A.
    Uthman, A. O.
    Liu, Z.
    Routh, K.
    Connock, M.
    Jobanputra, P.
    Moore, D.
    Fry-Smith, A.
    Chen, Y-F
    HEALTH TECHNOLOGY ASSESSMENT, 2011, 15 (14) : 1 - +
  • [42] Tumour necrosis factor blockade in rheumatoid arthritis
    Breedveld, FC
    CLINICAL MEDICINE, 2001, 1 (02) : 107 - 109
  • [43] Treatment of psoriatic arthritis with etanercept, a tumour necrosis factor antagonist
    Wong, VK
    Lebwohl, MG
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (11) : 1505 - 1513
  • [44] Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
    Neovius, M.
    Arkema, E. V.
    Olsson, H.
    Eriksson, J. K.
    Kristensen, L. E.
    Simard, J. F.
    Askling, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) : 354 - 360
  • [45] Influence of antibodies against infliximab and etanercept on the treatment effectiveness of these agents in Japanese patients with rheumatoid arthritis
    Hoshino, Motoaki
    Yoshio, Taku
    Onishi, Sachiko
    Minota, Seiji
    MODERN RHEUMATOLOGY, 2012, 22 (04) : 532 - 540
  • [46] Tumour necrosis factor α independent disease mechanisms in rheumatoid arthritis:: a histopathological study on the effect of infliximab on rheumatoid nodules
    Baeten, D
    De Keyser, F
    Veys, EM
    Theate, Y
    Houssiau, FA
    Durez, P
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (05) : 489 - 493
  • [47] Efficacy of etanercept in rheumatoid arthritis patients and its effects on interleukin-6 and serum tumor necrosis factor ?
    Li, Suihua
    Mei, Qinghua
    Qian, Dan
    Huang, Xianghong
    Fan, Cuimiao
    Quan, Jia
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (01) : 207 - 213
  • [48] Switching to etanercept in patients with rheumatoid arthritis with no response to infliximab.
    Di Poi, Emma
    Perin, Antonella
    Morassi, Maria Pia
    Del Frate, Marino
    Ferraccioli, Gianfranco
    De Vita, Salvatore
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (01) : 85 - 87
  • [49] Etanercept is effective in patients with rheumatoid arthritis with no response to infliximab therapy
    Gómez-Puerta, JA
    Sanmartí, R
    Rodríguez-Cros, JR
    Cañete, JD
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (07) : 896 - 896
  • [50] Drugs that block tumour necrosis factor: Experience in patients with rheumatoid arthritis
    Moreland, LW
    PHARMACOECONOMICS, 2004, 22 (02) : 39 - 53